Arkema (OTCMKTS:ARKAY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.
According to Zacks, “Arkema SA is engaged in the manufacturing and marketing of vinyl products, industrial chemicals, and performance products. Vinyl products include chlorine or caustic soda, pipes and profiles, PVC, and vinyl compounds. Industrial chemicals include emulsion systems, fluorochemicals, hydrogen peroxide, PMMA and methacrylics, specialty acrylic polymers and thiochemicals. Performance products include functional additives, specialty chemicals and technical polymers. The Company’s products can be used for various purposes including air conditioning or refrigeration; chemical processing, coating, construction; packaging; automotive & transportation. Its products, also find their application in adhesives and sealants, agriculture & agrochemicals, consumer goods, electronics, foams, solvents and aerosols market, health, hygiene & beauty, oil & gas, energy, pharmaceuticals, pulp & paper, rubber market, sports & leisure, etc. Arkema SA is headquartered in France. “
Separately, Credit Suisse Group lowered shares of Arkema from a “neutral” rating to an “underperform” rating in a report on Monday, November 13th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $137.00.
Arkema SA is a chemical producer, which provides specialty chemicals and advanced materials. The Company manufactures a range of products for industries, including construction, packaging, chemical, automotive, electronics, food and pharmaceutical industries. The Company operates through three business segments: High Performance Materials, Industrial Specialties and Coating Solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.